IMAX CORP. v. In-Three, Inc.

385 F. Supp. 2d 1026, 76 U.S.P.Q. 2d (BNA) 1861, 2005 U.S. Dist. LEXIS 24197, 2005 WL 1939708
CourtDistrict Court, C.D. California
DecidedJuly 21, 2005
DocketCV 05-1795 FMC (MCX)
StatusPublished

This text of 385 F. Supp. 2d 1026 (IMAX CORP. v. In-Three, Inc.) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
IMAX CORP. v. In-Three, Inc., 385 F. Supp. 2d 1026, 76 U.S.P.Q. 2d (BNA) 1861, 2005 U.S. Dist. LEXIS 24197, 2005 WL 1939708 (C.D. Cal. 2005).

Opinion

ORDER DENYING MOTION TO DISMISS FOR LACK OF SUBJECT MATTER JURISDICTION

COOPER, District Judge.

This matter is before the Court on the Motion to Dismiss for Lack of Subject Matter Jurisdiction (docket no. 45), filed June 7, 2005. The Court, having read and considered the moving, opposition and reply documents submitted in connection with this motion, hereby DENIES the motion for the reasons and in the manner set forth below. The Court deems this matter appropriate for decision without oral argument. See Fed.R.Civ.P. 78; Local Rule 7-15. Accordingly, the hearing set for July 25, 2005 is removed from the Court’s calendar.

I. Background

This patent infringement action relates to a method for converting two-dimensional films into three-dimensional media. On March 11, 2005, Plaintiffs IMAX Corporation (“IMAX”) and Three-Dimensional Media Group, Ltd. (“3DMG”) brought suit against Defendant In-Three, Inc. (“In-Three”) for allegedly infringing U.S. Patent No. 4,925,294 (“ ’294 Patent”). In this motion, In-Three contends that Plaintiffs lack standing to sue on the ’294 Patent and that the owner of the patent, an indispensable party, has not been joined.

On January 28, 2005, the inventor of the ’294 Patent, David Geshwind, assigned to 3DMG, of which he is president, all of his “right title and interest,” including “all right he may have to sue and recover for damages and other remedies in respect of any infringement of the Patents Rights which may have occurred before the date of this assignment.” See Weinstein Decl. at Ex. E. His co-inventor, Anthony Han-dal, also conveyed his “right, title and interest” in the ’294 Patent to 3DMG, including any right to sue to recover damages. Id. The copy of the January 28, 2005 assignment from Geshwind (“Geshwind Assignment”) to 3DMG that has been produced to In-Three is heavily redacted. All language has been redacted except the following: (1) a recitation of consideration; (2) a warranty that Geshwind is the owner of the patent; (3) a warranty that the ’294 Patent is valid and enforceable; (4) the language quoted above; and (5) a warranty that Geshwind will not interfere with the rights granted under the Patent.

On February 3, 2005, 3DMG granted to IMAX “the worldwide, exclusive right and license under the claims of the Licensed Patents [including the ’294 Patent] and Licensed Know How to make, have made use, lease, offer to sell, sell, import, and practice the Licensed Technology in the Field of Use. 3DMG further [granted] to IMAX the exclusive right and license to sublicense their rights to the License Patents [including the ’294 Patent] and the Licensed Know How in the Field of Use.” Weistein Decl. at Ex. B.

On March 9, 2005, Geshwind and Handal signed a “Confirmatory Assignment of Patent,” in which they confirmed the “transfer, conveyance, and assignment” of the ’294 Patent to 3DMG. The document reiterated that Geshwind and Handal assigned the ’294 Patent and the right to sue to 3DMG. The confirmatory assignment *1028 was signed nunc pro tunc, effective January 28, 2005, the date of the original assignment. Geshwind explained the purpose of the confirmatory assignment: “As of January 28, 2005, I believed that I no longer had any right, title, or interest in and to the ’294 Patent, all such rights then belonging to 3DMG, but in the Confirmatory Assignment I included operative language assigning any remaining title in the ’294 Patent, that I might be deemed to have still had, to 3DMG.” Geshwind Decl. at ¶ 6.

In-Three requested from Plaintiffs on numerous occasions an un-redacted copy of the original Geshwind Assignment, but Plaintiffs refused to produce such a copy. Plaintiffs represented to In-Three that the redacted portions pertained to the personal finances of Geshwind, which he wished to keep confidential. 1 Weinstein Decl. at Ex. J. Although In-Three argued that such information was not privileged, it did not bring a motion to compel the production of the unredacted copy. Instead, In-Three brought the instant motion pursuant to Fed.R.Civ.P. 12(b)(1) and 12(b)(7), arguing that the original assignment is an essential link in the chain of title giving Plaintiffs the right to sue. Without an unredacted copy, In-Three argues, Plaintiffs are unable to establish that they have standing.

II. Discussion

“A party may bring an action for patent infringement only if it is the ‘patentee,’ i.e., if it owns the patent, either by issuance or assignment.” Speedplay, Inc. v. Bebop, Inc., 211 F.3d 1245 (Fed.Cir.2000); 35 U.S.C. §§ 100, 261, 281. To show that it is the patentee, a plaintiff to whom the patent was not originally issued must produce a “written instrument documenting the transfer of proprietary rights in the patents.” Speedplay, 211 F.3d at 1250. Courts look to the substance of that writing to determine whether it has the effect of assigning the patent rights and accordingly satisfying the statutory requirement that the “patentee” must sue. Ortho Pharmaceutical Corp. v. Genetics Institute, Inc., 52 F.3d 1026, 1030 (Fed.Cir.1995). 2 The transfer of substantially all the patent rights may constitute an assignment. Id. (citing Vaupel Textilmaschinen KG v. Meccanica Euro Italia S.P.A., 944 F.2d 870, 875 (Fed.Cir.1991)). The plaintiff has the burden of establishing its standing to sue, and therefore, of establishing that an assignment has been made. Ortho, 52 F.3d at 1032-33.

While an assignee may bring suit, “[a] bare licensee, who has no right to exclude others from making, using, or selling the licensed products, has no legally *1029 recognized interest that entitles it to bring or join an infringement action.” Abbott Laboratories v. Diamedix Corp., 47 F.3d 1128 (Fed.Cir.1995). However, an exclusive licensee “may obtain sufficient rights in the patent to be entitled to seek relief from infringement.” Id. To do so, “it ordinarily must join the patent owner.” Id. This is because “[t]he presence of the owner of the patent as a party is indispensable not only to give jurisdiction under the patent laws, ...

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
385 F. Supp. 2d 1026, 76 U.S.P.Q. 2d (BNA) 1861, 2005 U.S. Dist. LEXIS 24197, 2005 WL 1939708, Counsel Stack Legal Research, https://law.counselstack.com/opinion/imax-corp-v-in-three-inc-cacd-2005.